LYSSN.IO, INC

Seattle, WA · Founded 2018 · Digital health · Private

AI software platform that analyzes clinical conversations and patient interactions to measure quality of care and deliver evidence-based training recommendations

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · lyssn.io

Sector: Digital health
Headquarters: Seattle, WA
Founded: 2018
Latest Form D: $300K, Apr 2025
Total capital: $13.2M

Federal grants: $11.9M; 19 awards · 2018–2024; Rank in peer group#25 of 35
Private capital raised: $1.4M; 2 Form D · last Apr 2025; 19 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

Latest events

Apr 2025Private capital raisedForm D · SEC · 2nd filing$300K
Nov 2024Federal grantHealth and Human S · Phase II · Voice-based AI to scale evaluation of crisis counseling in 988 rollout$840K
Jul 2024Federal grantHealth and Human S · Phase II · Enhancing the quality of CBT in community mental health through AI-generated fidelity feedback$697K
Nov 2023Federal grantHealth and Human S · Phase II · Voice-based AI to scale evaluation of crisis counseling in 988 rollout$998K
Jul 2023Federal grantHealth and Human S · Phase II · Enhancing the quality of CBT in community mental health through AI-generated fidelity feedback$610K
May 2023Federal grantHealth and Human S · Phase II · CBTpro: Scaling up CBT for psychosis using simulated patients and spoken language technologies$698K
May 2023Federal grantHealth and Human S · Phase II · Voice-based AI to scale evaluation of crisis counseling in 988 rollout$275K
Nov 2022Private capital raisedForm D · SEC · 1st filing$1.1M

Show 13 earlier federal awards

Aug 2022Federal grantHealth and Human S · Phase II · ClientBot: A conversational agent that supports skills practice and feedback for Motivational Interviewing for AUD$814K
Jul 2022Federal grantHealth and Human S · Phase II · Enhancing the quality of CBT in community mental health through AI-generated fidelity feedback$811K
May 2022Federal grantHealth and Human S · Phase II · CBTpro: Scaling up CBT for psychosis using simulated patients and spoken language technologies$752K
May 2022Federal grantHealth and Human S · Phase II · CBTpro: Scaling up CBT for psychosis using simulated patients and spoken language technologies$1.5M
Aug 2021Federal grantHealth and Human S · Phase II · ClientBot: A conversational agent that supports skills practice and feedback for Motivational Interviewing for AUD$855K
Aug 2021Federal grantHealth and Human S · Phase II · Enhancing the quality of CBT in community mental health through AI-generated fidelity feedback$460K
Feb 2021Federal grantHealth and Human S · Phase II · CBTpro: Scaling up CBT for psychosis using simulated patients and spoken language technologies$473K
May 2020Federal grantHealth and Human S · Phase II · ClientBot: A conversational agent that supports skills practice and feedback for Motivational Interviewing for AUD$397K
Mar 2020Federal grantHealth and Human S · Phase II · CBTpro: Scaling up CBT for psychosis using simulated patients and spoken language technologies$499K
Feb 2020Federal grantHealth and Human S · Phase II · Technology-supported, measurement-based supervision for Motivational Interviewing$135K
Dec 2019Federal grantHealth and Human S · Phase II · Technology-supported, measurement-based supervision for Motivational Interviewing$394K
Jan 2019Federal grantHealth and Human S · Phase II · Technology-supported, measurement-based supervision for Motivational Interviewing$553K
Jul 2018Federal grantHealth and Human S · Phase II · Technology-supported, measurement-based supervision for Motivational Interviewing$146K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

52months

from LYSSN.IO, INC’s first federal award to its first private round.

First federal award · Jul 2018: Health and Human S · $146K
First Form D · Nov 2022: $1.1M · 1st Form D
Awards before first raise: 13 awards

An association in public records, not a cause or a prediction.

Standing among 35 peers

Line = median

Digital health · Software

Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants

Michael J. TananaResearcherDirector, PromoterLinked by $1.2M in grants as PI
David C. AtkinsExecutive Officer, Director, PromoterNamed in SEC Form D filings
Seth J. FeuersteinDirectorNamed in SEC Form D filings
Zachary E. ImelDirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

23ANDME, INC.Similar federal contract value in Digital health · null in contracts
DECODE HEALTH, INC.Similar federal contract value in Digital health · null in contracts
KINIMA, INC.Similar federal contract value in Digital health · null in contracts
NOMA AI INC.Similar federal contract value in Digital health · null in contracts
HEALTH TEQUITY LLCSimilar federal contract value in Digital health · null in contracts
BIONIKS, INC.Similar federal contract value in Digital health · null in contracts

Regulatory activity · Digital health

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.